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Abstract
Background: Chile and Colombia are examples of Latin American countries with health systems shaped by similar 
values. Recently, both countries have crafted policies to regulate the participation of private for-profit insurance 
companies in their health systems, but through very different mechanisms. This study asks: what values are important in 
the decision-making processes that crafted these policies? And how and why are they used?
Methods: An embedded multiple-case study design was carried out for 2 specific decisions in each country: (1) in Chile, 
the development of the Universal Plan of Explicit Entitlements - AUGE/GES - and mandating universal coverage of 
treatments for high-cost diseases; and (2) in Colombia, the declaration of health as a fundamental right and a mechanism 
to explicitly exclude technologies that cannot be publicly funded. We interviewed key informants involved in one or 
more of the decisions and/or in the policy analysis and development process that contributed to the eventual decision. 
The data analysis involved a constant comparative approach and thematic analysis for each case study. 
Results: From the 40 individuals who were invited, 28 key informants participated. A tension between 2 important 
values was identified for each decision (eg, solidarity vs. individualism for the AUGE/GES plan in Chile; human dignity 
vs. sustainability for the declaration of the right to health in Colombia). Policy-makers used values in the decision-
making process to frame problems in meaningful ways, to guide policy development, as a pragmatic instrument to make 
decisions, and as a way to legitimize decisions. In Chile, values such as individualism and free choice were incorporated 
in decision-making because attaining private health insurance was seen as an indicator of improved personal economic 
status. In Colombia,  human dignity was incorporated as the core value because the Constitutional Court asserted its 
importance in its use of judicial activism as a check on the power of the executive and legislative branches.
Conclusion: There is an opportunity to open further exploration of the role of values in different health decisions, 
political sectors besides health, and even other jurisdictions.
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Implications for policy makers
• Understanding how social values are incorporated into health policy decision-making is important for policy analysis.
• The interplay between technical, social, and political values are important to designing policies that meet the needs of the population and 
responding to citizens’ preferences. 
• Policy-makers simplify the complex interplay of values by prioritizing only those considered essential for the policy process.
Implications for the public
All policy decisions are value-laden; however, it is not clear how values play a role and why some values are prioritized. This study analyzes the values 
prioritized in 4 health system financing decisions regarding the materialization of the right to health, the designing of benefits plans, and the decision 
of publicly fund high cost technologies. This study supports the public understanding of how particular proposals or initiatives should align with the 
national mood to influence the decision-making.
Key Messages 
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Background 
Values, defined as “principles, or criteria, for selecting what 
are good (or better, or best) among objects, actions, ways of life, 
and social and political institutions and structures,”1 play an 
essential role in informing policy choices among options that 
could be used to achieve particular goals in health systems.2-4 
In decision-making about health-system financing, social 
values, referred to sensibilities dealing with general social 
functioning5 such as efficiency, equity, quality, sustainability, 
and universality, are often embedded at all stages of the policy 
process but is not clear how they are incorporated.6 Moreover, 
understanding the role of those social values is challenging, 
given the wide range of values prioritized by different 
stakeholders and the many ways in which values can inform 
policy decisions.7 
Latin America has provided a vibrant context for a study of the 
role of values given its many recent political transformations. 
In the last 40 years, many countries in the region have moved 
from dictatorships to democracies, democratic governments 
have been run by right-wing, centrist and left-wing parties and 
there has been unequal economic growth within and across 
countries. These factors have contributed to different values 
being prioritized in policy decision-making in each country 
and therefore used to shape the many efforts to reform health 
systems in the region. 
Different authors have addressed the role of values in the 
health policy decision-making process in Latin America, 
principally focusing on values in health-system reforms.8-10 
Those approaches were captured in our critical interpretive 
synthesis, which identified 116 values in empirical and non-
empirical papers about the role of values in policy decision-
making in Latin America. Through the critical interpretive 
synthesis we developed a theoretical framework, tested in 
this study, which characterized values in 4 ways: (1) goal-
related values (ie, guiding principles of the health system); 
(2) technical values (those incorporated into the instruments 
adopted by policy-makers to ensure a sustainable and 
efficient health system); (3) governance values (those applied 
in the policy process to ensure a transparent and accountable 
process of decision-making); (4) situational values (a broad 
category of values that represent competing strategies to 
make decisions in the health systems). These categories of 
values come to be influential in government agenda setting by 
framing the problems in specific ways, by prioritizing some 
health issues in the government agenda, or by giving legitimacy 
to the process of agenda setting.10 In policy development, 
values are used as pragmatic instruments to inform policy 
development, influence what policy options are more likely 
to be chosen, and to improve the acceptability of the policy 
options that are selected.11 In policy implementation, values 
influence which policies are more likely of being prioritized 
for implementation, are used as indicators for evaluating 
the general performance of the health system and are used 
as indicators of good governance and as strategies against 
corruption. 
Chile and Colombia are examples of 2 Latin American 
countries with a rich historical context for health-system 
financing decisions. Chile, in 1981, during the Pinochet’s 
dictatorship, and Colombia, in 1993, during a democratic 
government, reformed their health systems, introducing for-
profit private health insurance companies.11-13 Since then, a 
two-tiered health system has existed in both countries.
In Chile, citizens can be affiliated either with a single 
national public insurer (the National Health Insurance Fund, 
Fondo Nacional de Salud or FONASA), or with private health 
insurance institutions called ISAPRES (Instituciones de Salud 
Previsional), which operate under the logic of premiums 
adjusted to individual risk.14-16 At the end of the Pinochet 
dictatorship in 1989, the period of transition to democracy 
was led by 4 consecutive governments belonging to a coalition 
of centre and centre-left parties. The first 2 transitional 
governments implemented minimal changes to the privately 
financed health system. As consequence of this “voluntary” 
and “market regulated” health system, in 2001, FONASA 
provided healthcare coverage for the majority (67%) of 
the Chilean population, while ISAPRES covered 19% of 
Chileans.17 As would be expected, those receiving coverage 
through ISAPRES are individuals from the top-two income 
quintiles, with a higher proportion of men and youth than the 
average Chilean population, which represent those with the 
lowest risk profiles in the population.18
In Colombia, the reform defined benefits packages to 
be provided under a national insurance system through an 
individual capitation scheme that includes a contributory 
regime for employees and a subsidized regime for 
unemployed and low-income families. The benefits of the 
subsidized basket of health services were approximately 
half the benefits in comparison to the contributory regime’s 
basket, which created an important source of inequity in the 
design of the system itself.13,19 An important contextual factor 
in Colombia is the introduction, in the Constitution of 1991, 
of the tutela, which is an informal and expedited injunction 
that allows individual claims for judicial protection when 
fundamental human rights are threatened by the state or by 
a third party.13 The introduction of this provision opened the 
door to a significant increase in litigation in relation to rights 
enshrined in the Constitution, including those related to the 
right to health,20 and strengthened the role of the judicial 
system in issues related to health policy, which provided the 
Constitutional Court a great deal of legitimacy in shaping 
health policy in the country. 
In this research, we wanted to know: (1) what declared 
and undeclared values are important in the decision-making 
processes that crafted 4 particular policies? (2) how do policy-
makers use values in these processes? and (3) why are some 
values incorporated?
 
Methods
This study employed a qualitative multiple-case embedded 
design21 with 2 cases and 2 embedded units within each case. 
The choice of a multiple-case study design was driven by the 
comparative nature of our research question and the ability of 
this design to produce robust results.21 An embedded design 
was preferred given the nested nature of the context in which 
2 different health-system financing decisions were made in 
each of the country cases.
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Case Selection
Within each country, 2 policy decisions were chosen as 
embedded units. Both decisions in each country needed 
to represent a significant shift in health-system financing 
policy as part of the health-system reforms. In each country, 
we selected one broad-reaching structural political decision 
(affecting financial arrangements as well as delivery and 
governance arrangements), and another with a narrower 
focus on resource allocation within the context of the broader 
structural reforms. Both of the structural decisions were 
implemented within the last 10 years, while the narrower 
decisions were made (since 2015). For Chile, we selected 
the development and implementation of the Universal Plan 
of Explicit Entitlements (AUGE or garantías explícitas de 
salud [GES]), which is a universal care plan designed to make 
medical coverage available to all Chilean citizens suffering 
from one of a specified, but growing list of diseases (80 at 
2018). For the second decision, we selected the approval of 
a law mandating universal coverage of technologies for high-
cost diseases (known as the Ricarte Soto Law), which provides 
financial protection for technologies associated with specific 
high-cost diseases to all citizens regardless of sector affiliation 
(public or private) or socioeconomic status.
For Colombia, we selected the declaration of health as a 
fundamental right, which implies a change in the notion of 
health as a public service (first with the rule T-760 and later 
with the Statutory Law). For the second decision, we selected 
the mechanism established by the Health Ministry to explicitly 
exclude technologies that cannot be publicly funded.
Selection of Participants and Sampling
The selection of participants ensured a balance of perspectives 
of people involved in the policy decision-making process for 
each of the decisions selected. We used three criteria to define 
the sample frame. First, the involvement in the policy decision-
making process, defined as being directly involved in one or 
more of the decisions included in our case study and/or in the 
policy analysis and development process that contributed to 
the eventual decision. Second, the type of government in Chile 
and Colombia. Both countries have a presidential bi-cameral 
regime with a separation of powers under which the state is 
divided into branches (the legislative, executive and judicial), 
each with separate and independent powers and areas of 
responsibility. Third, a balance of perspectives of stakeholders 
and policy-makers from the national and local level, and in 
favour of and opposition to the decisions. Based on this, we 
created a set of categories of types of roles or positions that 
could have been involved in the decisions. These included 
policy-makers (ie, from the health ministry, the health 
technologies assessment institutions or commissions, public 
health authorities and local governments; congressmen; 
and judges in the case of Colombia) and stakeholders (ie, 
academic authorities, medical and other health professional 
associations, hospitals and insurance managers, and advocacy 
coalitions comprising the aforementioned groups). Using 
this categorization scheme, we developed a sample frame of 
participants from individuals identified through our previous 
knowledge of the decisions by searching government and 
organizational directories for those who might have been 
involved in the decisions, and by asking interview participants 
to identify others who were involved.22
The sample frame was used to select a purposive sample of 
participants to invite for a qualitative interview. The purposive 
sampling sought to achieve: (1) maximum variation to ensure 
a range of key informants was sampled based on their position 
(ie, a mix of policy-makers and stakeholders); and (2) the 
engagement of individuals who could offer rich insights (eg, 
those who played multiple roles). We planned to interview 
between 12-24 participants in each country to ensure a 
breadth of perspectives across each of the policy-maker and 
stakeholder groups (roughly 6-12 interviewees from each 
group in each country) and to reach thematic saturation (ie, 
when no new themes emerge from the last 2-3 interviews).
Field Procedures
We used an in-depth semi-structured interview approach to 
explore participants’ views and experiences about the three 
objectives of our study.23 Participants were contacted by 
email with follow-ups by email and then by phone call when 
necessary and invited to participate in a semi-structured 
interview of an approximate duration of 60-90 minutes. Those 
who agreed to participate were interviewed in-person, or by 
video-call when an in-person interview was not possible. 
The principal investigator (MV) performed all the 
interviews, using a semi-structured interview guide. We 
provided several examples of values commonly related to 
health policy decision-making, including those explicitly 
stated in the laws that organize and regulate the health 
systems in Chile and Colombia. The interview guide included 
questions related to the general process of decision-making 
about health-system financing and about each of the decisions 
included. In each of these three areas, we included prompts 
related to each of the three questions. We iteratively revised 
the interview guide as needed to allow for exploration of 
emerging themes and to explore assumptions or statements 
made by other participants. 
Each participant was asked to review and sign an 
informed consent form and was asked permission to record 
the interview. The audio recordings and transcripts were 
stored on a secure password-protected laptop. Interviews 
were conducted, transcribed and analysed in Spanish, and 
translated to English during the process of drafting the 
analysis of the results.
Data Analysis
A thematic analysis was conducted using a constant 
comparative approach for each case study. Information was 
coded using three frameworks: (1) Kingdon’s government 
agenda-setting framework, which uses three ‘streams’ of 
factors (problems, policies, and politics) to explain why some 
issues garner government attention and why some issues are 
elevated to the point of being up for active decision24; (2) the 
3I+E framework, which focuses on the role of institutions, 
interests, ideas, and external factors in shaping policy 
choices25; and (3) the values framework discussed previously.
First, data was examined through an open coding process 
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by the principal investigator (MV), the codes were reviewed 
by grouping themes that are similar theoretically or connected 
in meaning, using the three frameworks outlined above. We 
created a list of codes that consisted of a catalogue of themes, 
issues, accounts of values, and opinions that relate to the 
process of policy decision-making across the cases. Based on 
these codes, the computer program ATLAS.Ti was used to 
generate a series of categories arranged in a treelike structure 
connecting text segments grouped into separate categories 
of codes or ‘‘nodes’’ to further the process of axial or pattern 
coding to examine the association between different a 
priori and emergent categories. The a priori categories were 
determined using Kingdon, the 3I+E framework, and our 
societal values framework, as the guide for the initial analysis. 
Then based on the initial coding, additional themes were 
derived and used to further code the data. MGW and GP 
reviewed the coding process and reassigned categories when 
necessary. A brief summary was sent to one participant in 
each country as strategy of member checking of the data 
analysis process.
Finally, we developed policy analyses in each country 
by: (1) identifying what values have informed the policies 
selected, and to understand how and why those values were 
used in that specific context; (2) describing stakeholder and 
policy-maker perspectives and insights about specific values 
identified in the interviews; and (3) comparing how these 
perspectives differ.
Results 
Forty stakeholders and policy-makers were invited to 
participate in the study (20 in each country), and a total of 28 
key informant interviews were completed (9 in Chile and 19 
in Colombia) (see characteristics of participants in Table 1). 
From the group of 12 individuals who were invited but did 
not participate, 5 declined, 5 did not reply, and 2 could not 
participate due to scheduling conflicts despite repeated 
attempts to find a time that worked for them. The interviews 
ranged from 33-108 minutes in length, with an average 
duration of 55 minutes (54 minutes in Colombia, 57 minutes 
in Chile).
In this section we provide a descriptive narrative of 
Table 1. Summary of Participants by Role and Country
Type of Participant Chile Colombia
All participants 9 19
Policy-maker 3 7
Executive branch 3 4
Legislative branch 0 2
Judicial branch 0 1
Stakeholder 6 12
Manager 1 3
Health professional 6 11
Member of a coalition or stakeholder group 2 7
Researcher 6 6
Policy-maker and stakeholder are exclusive categories. 
Sub-categories of stakeholders are not exclusive.
each of the decisions selected, identify what values were 
important in the decision-making processes that crafted 
those policies (ie, effectiveness, free-choice, human dignity, 
individualism, social participation, solidarity, stewardship, 
and sustainability); describe how those values were used (eg, 
framing problems in meaningful ways, guiding the policy 
development process, using them as pragmatic instruments 
to make decisions, and using them to legitimize decisions); 
and explain why these particular values were incorporated in 
the 4 decisions addressed.
Main Findings in Chile
First Embedded Decision: AUGE/GES Plan
In the 1990s, politicians and stakeholders continuously 
criticized the performance of the Chilean health system given 
the feedback about how the system was failing to provide 
timely access to needed services. Values played a significant 
role in framing the problems of the Chilean health system and 
setting them on the governmental agenda. Feedback from the 
operation of current programs showed a lack of affordability 
for needed care due to limited to no coverage for certain 
diseases and health conditions and higher premiums for some 
populations (eg, older adults and women of child bearing age) 
in the privately financed system. In addition, poor quality 
of and lack of timely access to care in the publicly financed 
system was identified as a significant and persistent issue. 
Following the election of a new president (Ricardo Lago), the 
issue gained further prominence with his proposal of a health 
reform that would make the system more accessible, which 
appeared technically feasible and enjoyed public support in 
the aftermath of a recent election. 
Several factors emerged from our analysis as being critical 
to supporting and also potentially limiting the likelihood 
of developing and implementing the AUGE/GES plan. The 
main factors supporting its development included: (1) the 
commitment to the proposal by the newly elected president 
Lagos, who were mostly unconstrained in their executive role; 
(2) the lobbying of patient groups who requested the inclusion 
of specific diseases to the plan (which helped to shape the 
focus of the plan on covering specific diseases and treatments 
for them); (3) the use of the right to health rhetoric in the 
discussion of the reforms which improved the acceptability 
of the proposal; and (4) the alignment of the plan with the 
proposal of basic universalism of the World Bank (as an 
external factor). In contrast, three factors appeared to have 
played against the development of the AUGE/GES plan: (1) 
the need to alter strong policy legacies of the health system 
established by Pinochet (which meant altering existing 
resources and incentives to groups in the system); (2) the 
opposition of private insurance companies to the solidarity 
fund proposed by the government (given that they would 
lose market share and revenue); and (3) the prevailing value 
of Chileans that access to private insurance as an indicator 
of improvement in their economic status and their social 
mobility (meaning that an enhanced public role could be seen 
as limiting their achievement of social mobility).
According to the interviewees, overcoming these competing 
factors to develop and implement the AUGE/GES Plan was 
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achieved by careful balancing of the discordant values of 
free choice and individualism and the need for solidarity 
in the financing arrangements for the health system. Three 
mechanisms for how these values influence the decision-
making were identified, which include framing problems in 
meaningful ways, guiding the policy development process, 
and as a way to ensure social mobility among citizens 
(see Table 2 for a description of how values were used). 
Regarding framing the problems, a contradiction between 
these sets of values appeared when considering that payroll 
taxes finance both the publicly and privately financed health 
systems. However, the publicly financed system is available 
and accessible for all Chileans, but in the privately financed 
system, employees use their payroll contribution to pay for 
individual private insurance (for the affiliate and his/her 
family), and these resources are not shared with the publicly 
financed system or with those who are sicker or have lower 
incomes. In guiding the policy development, solidarity was 
understood by some interviewees as the social duty of private-
plan participants to share their contributions with all the 
Chilean population through a common fund. In contrast, 
interviewees understood the value of individualism as the 
desire of some Chileans to belong to an elite group with 
access to services that differentiate them from the general 
population. In this scenario, insurance companies pressed 
to maintain the status quo, because they could continue to 
benefit from the profits of this scheme in which high-income, 
low-risk individuals pay high premiums only to cover their 
own healthcare needs. Some of the interviewees stated that 
President Lagos’ proposal included a compensation solidarity 
fund as an attempt to reconcile these values, but this proposal 
lacked the political support of parties on the right of the 
political spectrum which, at least in part, represented the 
interests of private insurers. As a result, several actors consider 
that the reform ultimately took fell short in terms of seeking 
solidarity through the system.
All interviewees agreed that the decision on which diseases 
and services to include in the AUGE/GES plan was ultimately 
guided by a focus on technical values, particularly relevance/
importance to achieving public health goals for the first, and 
effectiveness, financial sustainability, and budget availability, 
for the decision about what to include in the covered basket 
of services. Those values where used through 2 mechanisms, 
as pragmatic instruments to make decisions and as strategy 
to legitimize decisions were meant to deflect attention from 
budget constraints. 
Interviewees also highlighted that the inclusion of cystic 
fibrosis as one of the first 25 diseases included in the AUGE 
plan, was influenced by the engagement of patients and 
citizens, principally, by the mobilization of the interests of 
parents of children with the disease. Interviewees indicated 
that the inclusion of cystic fibrosis arose a contradiction in 
the policy-development process between technical values 
prioritized by policy-makers and social values advocated 
for by civil society. For some policy-makers, decisions that 
prioritize social values advocated by civil society, led people to 
view the policy process as lacking accountability, credibility, 
and transparency, given that interest groups influence the 
decision. In contrast, stakeholders and some policy-makers 
considered that decisions only informed by technical values 
lack accountability, credibility, and transparency.
Second Embedded Decision: The Ricarte Soto Law
The Ricarte Soto Law emerged as a response to a focusing 
event. When the journalist Ricarte Soto was diagnosed 
with lung cancer he became aware of the economic barriers 
that patients like him face when trying to access needed 
treatments, particularly high-cost treatments not included 
in the AUGE/GES Plan. This awareness led the journalist 
to promote a social movement advocating for a policy that 
guarantees access to treatments for high-cost diseases, which 
subsequently garnered political support in the form of a 
programmatic proposal of the presidential candidate, Michell 
Bachelet, who promised a fund to cover drugs associated with 
complex and high-cost diseases.26 
Four factors supported the development of the Ricarte Soto 
Law: (1) the governing party supported the initiative (ie, it 
was programmatic proposal of the newly elected president); 
(2) the social mobilization and lobbying efforts of patient 
groups made highly visible requests for the coverage of 
specific technologies; (3) intense media coverage fostered 
further support among the Chilean population, which was 
a key factor in changing the national mood to support the 
initiative; and (4) the need for the newly elected president 
Bachelet to develop a policy that improved her public image 
and helped her recover support among citizens (given than 
in other political areas she was losing favourable public 
opinion). Given that the Ricarte Soto proposal did not affect 
the profits of insurance companies nor the public budget of 
the government, the proposal had little opposition. 
According to the interviewees, the key values that 
underpinned the proposed policy were equity and, to a lesser 
extent, social participation. Those values were used to framing 
problems in meaningful ways, guiding the policy development 
process, and as strategy to legitimize decisions. Equity was 
identified in relation to financial protection (ie, that need and 
not ability to pay should determine coverage for high-cost 
diseases), and also in relation to access to services irrespective 
of type of disease (ie, that patients with rare diseases should 
be able to access treatments they need in the same way that 
patients with more prevalent medical conditions). Social 
participation was identified as the other significant value 
in the context of the importance of being responsive to 
social requests for policy action to address an issue and its 
prioritization ultimately rewarded the government with 
citizen support and favourable public opinion. 
Overall, most of the interviewees indicated that the focus 
of health policy decision-making should be on optimizing 
benefit to society as opposed to making decisions to solve 
individual cases. Accordingly, if the focus is to make decisions 
that benefit society, interviewees argued that technical 
values such as disease burden (ie, disease prevalence and 
severity of the conditions), and the effectiveness and cost-
effectiveness of interventions to address them should be 
used by policy-makers and stakeholders. However, policy-
makers and stakeholders stated that clear technical criteria to 
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Table 2. How Values Were Used in Each Embedded Decision in Chile
Values Identified Explanation of How the Values Were Used
Decision 1 - Regime of Explicit Health Guarantees (AUGE/GES Plan)
Goals-related values
•	 Accessibility
•	 Quality
•	 Solidarity
•	 Timely access
To frame the problems of the health systems in meaningful ways for stakeholders and citizens 
For example, solidarity was framed in this way:
•	 Payroll taxes finance both public and private health systems in Chile. However, the public system is available and accessible for all Chileans, but in the private system, employees use their payroll 
contribution to pay for individual private insurance (for the affiliate and his/her family), and these resources are not shared with the public system, neither with those who are sicker or have lower 
incomes. 
♦	 "But of course, if this guy is here [the private system], but tomorrow, the basic conditions for which he was there fail, and he came down, there was a network down there, as in the circus, then he 
fell off the trapeze, and fell on this basic network, which is the public system, which is your last-term insurance” (Stakeholder 11).
To guide policy development from the perspective of an enforceable right to health 
•	 The right to Health underpinned the specific goals-related values that guided the development of the AUGE/GES plan. Those goals were: (1) an enforceable right to health; (2) the definition of treatment 
protocols and specific interventions necessary for treating the medical condition [quality]; (3) the adoption of maximum waiting times for each condition [timely access];  (4) the adoption of limits on 
out-of-pocket spending according to the family’s income [accessibility]; and (5) the creation of a solidary fund to finance the public system [solidarity]. 
♦	 " So, we recognize, first of all, that GES is a mechanism to make explicit the right to health, and therefore, it also makes explicit what is not guaranteed. So what was taken as philosophy was to say: 
you know what? we are going to make the right to health explicit, that is, we are not going to say that people have the right to health in generic terms and then we see what happens, but we are 
going to say what people are entitled to, and what is legally required, this means, legally established and enforceable" (Stakeholder 11).
Technical values
•	 Effectiveness
•	 Evidence-based
•	 Financial protection
•	 Rationality
•	 Relevance/importance to 
public health goals 
•	 Rationing
Pragmatic instruments to develop the policy and decide which diseases and conditions should be included
•	 All interviewees agreed that the decision on which diseases and services to include in the AUGE/GES plan was informed by technical values, mainly considering effectiveness and relevance/importance 
to public health goals.
Pragmatic instruments to define the baskets of services that are funded for each condition included
•	 The definition of the benefits basket for each disease that can be funded, either with public resources in FONASA or with premiums in the ISAPRES, depended on a combination of clinical effectiveness 
and budgetary limitations to cover clinically effective services.
To legitimize decisions that were meant to deflect attention from budget constraints 
•	 In defining what was included and excluded from the baskets of services, the value of rationing was weighted more than the value of rationality and, as a result, stakeholders perceived that the creation 
of some baskets of services lacked common sense and hid budget constraints (Stakeholders 11 & 12 and Policy-maker 14).
♦	 "We said OK cataract, let's operate on cataracts, but we said let's operate only on one eye. But how? if there is an X percent who has bilateral cataracts, why are we going to operate on one eye 
and not the other? ... At that time the story was like this, it is better to have a one-eyed man than a blind man, there's no money for everything, so it is better to have a one-eyed man than a blind 
man, we are going to operate on one eye, and is very clear" (Stakeholder 12).
Governance values
•	 Accountability
•	 Social participation
•	 Transparency
To legitimize the policy development process
•	 Participation of patients and citizens in the process of deciding on the conditions to be included in the AUGE plan improved the social perception about the capacity of the government to respond to 
social needs.
•	 However, participation of patients and citizens also appeared to reduce the credibility and transparency of the process as a result of the seemingly disproportionate influence of some groups such as 
parents of children with cystic fibrosis.
♦	 "And that is what happens with the Holocaust phenomenon, when you see the film, and you focus on a case where a child is murdered; the pain, we all fall tears. But you know that millions 
died, and when you know that millions died, it's like the pain diminishes. It is a psychological phenomenon. But you cannot ask that to a normative body, a normative body is supposed to feel 10 
times the pain when there are 10 cases, or 100 times or a thousand times, that is the difference between the normative and the emotional descriptive. So, what is happening here is that there is 
a value in positioning this index case. Then, you put a child with cystic fibrosis in the media, and it appears, it is in the minds of all individuals in the society, and then cystic fibrosis has to be, and 
you generate and occupy that psychological mechanism, and that psychological mechanism enters into the agenda and has an effect on society. Moreover, that happens because there is not a 
structured normative body filtering that, that allows putting that in the balance with other things, where there is probably more pain, in sum. What's the name of that social value? I do not know 
how it's called" (Stakeholder 12).
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Values Identified Explanation of How the Values Were Used
Situational values
•	 Free-choice
•	 Individuality
As a way to ensure social mobility among citizens
•	 Several Chileans consider the health insurance as a market (private) good that can only be accessed through an individual’s purchasing power. 
•	 Several interviewees stated that Chileans give importance to the free-choice of joining the private sector, because an improvement in their economic status that makes them eligible to belong to the 
private health system is an indicator of social mobility.
♦	  “Then, you have a society like this. Suddenly one of the trapezes falls, and suddenly we see some of those who are here [down] who improve the conditions; guess what they do? He quickly 
moves here [for the private one]. Why? Because he escapes the vices and complications of the public system, which are typical, the waiting list, the deal, and that ... somehow, let's say, his 
change of social status has attached the sticker: I´m in ISAPRE, this is part of his social repositioning" (Stakeholder 11).
Decision 2 - Fund for Health Coverage of High-Cost Diseases (Ricarte Soto Law)
Goals-related values
•	 Equity
To frame the problems in meaningful ways for stakeholders and citizens
•	 The journalist Ricarte Soto framed the problem of the lack of coverage of treatments for high-cost diseases as an equity problem and highlighted that patients in the private system had timely access 
to those technologies but patients in the public system faced several barriers.
Technical values
•	 Effectiveness
•	 Financial protection
•	 Safety
Pragmatic instruments to develop the policy, decide which diseases and conditions should be included and to define the technologies and services covered
•	 The criteria to decide which diseases were included in the Ricarte Soto Fund was the financial impact that treatments caused to families. To decide which technologies to cover with the fund, the 
criteria was the effectiveness and safety of the interventions. Given that the treatments are high-cost, values such as cost-effectiveness or disease burden were not prioritized in making this decision.
♦	 "I strongly would say that financial protection. The fact that nobody can die for not having a way to pay for her high-cost treatment, regardless of whether it was rare or not rare diseases. That 
was the strongest concept, and that is why the central proposal was to create a drug fund. It translated into what do we do as a country to protect these people from having their lives go to ruin 
by having to pay for these expensive medicines? Moreover, hand in hand, those who are most affected, that are the poorest, the middle class, and therefore the proposal had a content of equity, 
then it is like a mixture between both, and from that citizen´s feeling was that the public policy born in this government" (Policy-maker 17).
Governance values:
•	 Accountability
•	 Citizen engagement 
•	 Social participation 
•	 Transparency
To prioritize which conditions and technologies to include
•	 The participation of different patients’ groups in the process of prioritization implied discussions among those participants and the policy-makers to decide which conditions and technologies would 
be funded with the Ricarte Soto Law.
To improve the acceptability of the policy
•	 Participation of patients and citizens in defining the conditions included in the Ricarte Soto Fund improved the social perception about the capacity of the government of giving answers to the social 
needs. 
Abbreviations: FONASA, The National Health Insurance Fund, Fondo Nacional de Salud; ISAPRES, Instituciones de Salud Previsional; GES, garantías explícitas de salud;  AUGE, Universal Plan of Explicit Entitlements.
Table 2. Continued
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balance differing interests in the system do not exist, which 
makes robust citizen engagement important to help ensure 
transparency and accountability in the face of competing 
technical and societal interests.
Main Findings in Colombia
First Embedded Decision: Declaration of Health as a Fundamental 
Right
Between 1999 and 2008 the number of tutelas filed regarding 
health claims had increased by 300%.27 Some of these tutelas 
included claims for healthcare services “excluded” from the 
benefits plans of each regime. However, most of the claims 
were to enforce coverage for technologies and services already 
included in benefits plans that health insurance companies 
unlawfully denied.19 Most of these tutelas were granted to 
the plaintiffs, which made judges the last recourse to decide 
which health benefits citizens are entitled. This situation and 
the lack of compliance with the process established in the 
transitional rules of the health system in 1993 for updating 
and equalizing the contributory and subsidized benefit plans 
by the year 2002, led to the active role of the Constitutional 
Court, who seeking to reconfigure the social values with 
which health policy decisions are made, mandated the right 
to health as the focus of decision-making about health policy 
in Colombia. As a result, the judicial sector was the central 
driving force behind the focus on upholding the right to health 
being prioritized on the decision agenda of the Colombian 
government. 
In 2008, the Constitutional Court passed the Rule T-760, 
which ordered a series of structural changes to the health 
system. For instance, the Court ordered the government 
to take the necessary steps to unify the 2 regimes of health 
coverage, and to update the benefits included in the new 
unified plan. While the Government timidly began a process 
of elaborating plans and policies to comply with the orders 
of the Constitutional Court, the private insurance companies 
continued to deny services included in the benefits plans, 
and as consequence tutelas continued to increase between 
2010-2014 to approximately 107.000 each year.28 Preceded by 
2 failed policies developed to solve these problems in 2010 
and 2011 (the Social Emergency in Health and the Law 1122), 
the government of Juan Manuel Santos presented a Statutory 
Law bill to the Congress in 2013, which passed after changes 
introduced by the Constitutional Court. The Statutory Law 
declared health as a fundamental right and de-incentivized 
litigation on costly healthcare services by forbidding the use 
of public funds to reimburse cosmetic and experimental 
medical treatments demanded by patients.29
The most important values in this embedded decision were 
human dignity, financial sustainability, and stewardship. 
Four mechanisms for how values influence the decision-
making were identified, which include framing problems in 
meaningful ways, guiding the policy development process, to 
gain legitimacy in the policy-making process in the absence 
of meaningful citizen participation, and to shape policies in 
a way that is aligned with the ideas of an influential interest 
group (see Table 3 for a description of how values were used).
According to the interviewees, the increase in tutelas was 
framed in terms of a threat to the financial sustainability 
of the health system (given the expensive payments for 
reimbursements to the private insurance companies), and as 
a violation of human dignity (given that the legal rules for the 
provision of healthcare were not being upheld and judges had 
to intervene on individual cases). Some of the policy-makers 
interviewed (belonging to the executive branch) criticized the 
policy development promoted by the Constitutional Court, 
arguing that it only considered the value of human dignity and 
neglected the value of financial sustainability, they suggested 
that the Court supported the right to health in theory but did 
not define the limits of that right. This meant that any request 
for direct or indirect healthcare ended up being protected by 
the right to health under the principle of human dignity (eg, 
diapers, food, payment of salary to family caregivers, etc), 
which put the financial sustainability of the health system 
at risk. For other policy-makers (belonging to the judicial 
branch) and for the stakeholders, financial sustainability was 
relegated to a factor that helps to guarantee the right to health 
for all.
All interviewees emphasized the importance of placing 
explicit boundaries on the package of benefits to which 
Colombians are entitled given that the health system is unable 
to provide everything to everyone. Some participants pointed 
out that by means of tutelas and allegations, expensive 
technologies were being funded for low-prevalence diseases 
and only for citizens who could navigate the judicial system 
(mainly middle- and upper-middle classes). Therefore, 
communicable and prevalent diseases in impoverished 
regions were not being addressed, which was highlighted as 
an important violation of the collective right to health at the 
expense of assuring individual rights to health through those 
seeking benefits through tutelas.
While emphasizing the importance of establishing limits to 
the benefits basket, participants identified 5 factors that made 
it complicated to achieve: (1) distrust of stakeholders and 
policy-makers about the hidden interests of other stakeholders 
and policy-makers (eg, corruption, pursuing of additional 
profits); (2) difficulty in establishing social participation 
mechanisms (eg, with citizens, patients, interest groups) that 
ensure transparency and meaningful consideration of all 
the interests of interested parties; (3) perception of citizens, 
patients and doctors that giving up benefits (from the benefits 
basket) is unfair in view of that private insurers and private 
providers are not giving up part of their profits; (4) perception 
that scientific evidence or technical criteria used to define 
the benefits baskets are tied to the interests of the medical 
industrial complex or that they do not consider the values and 
preferences of the citizens; and (5) fear that health resources 
will be lost through corruption and not used to cover the real 
needs of the population.
This mistrust among health system actors is fueled by 
the low level of social participation in the development 
and implementation of policies regarding the financing of 
the health system and using guiding values as ‘shields’ for 
engaging in meaningful deliberation. The policy legacy of 
power concentrated in the executive branch of government 
through the president meant the government could avoid 
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Table 3. How Values Were Used in Each Embedded Decision in Colombia
Values Identified Explanation of How the Values Were Used
Decision 1 - Declaration of Health as a Fundamental Right
Goals-related 
values
•	 Equality
•	 Quality
•	 Right to health
•	 Universality
To frame the problems of the health system in meaningful ways for stakeholders and citizens
For example, right to health was framed in this way:
•	 The Constitutional Court inferred the right to health from the right to life (doctrine of connection). The meaning was that although right to health was not declared as a fundamental right in the Constitution, it 
could become fundamental and enforceable by its connection to the right to life.
♦	 "But when the Court realized that there were many concrete cases in which the principle that the court believed was the first or of value, was disregarded, then it said, all this is bad, it is no longer this concrete 
case, it is all the system, all is wrong, is not working" (Stakeholder 16).
Value-based framing of problems shape viable solutions to achieve desired goals
•	 The problem was primarily framed in relation to the lack of stability and financial sustainability of the Colombian health system, as well as an overburdened judicial sector from the significant increase in tutelas, 
which ultimately exposed the more general flaw in achieving the protected value of the right to health in Colombia.
•	 Within this framing, 2 sets of policy options emerged which focused on reducing the number of tutelas by: 
1) Controlling what is requested by doctors and monitoring, auditing and regulating the payments of reimbursements due to tutelas (informed by values  of sustainability, protection of the state resources, 
and the enforcement of regulation); and
2) Protecting the right to health, updating the baskets of benefits, and ensuring appropriate healthcare delivery to citizens (based on values  such as accessibility, continuity of healthcare, comprehensiveness, 
equity and ‘human dignity’ as it relates to the judicial branch).
Technical values
•	 Efficiency
•	 Evidence-based
•	 Sustainability
To achieve the goals of the health system with efficiency and sustainability
•	 The Constitutional Court considered technical values  as necessary instruments to achieve the right to health and assurance of human dignity.
♦	 "I think we have to tune the two, what is important is that sustainability is not an end in itself, it is an aim precisely to achieve the protection of rights, and it has to be taken very seriously and not be regarded 
as a general argument. As we know resources are missing, as we know there are these limitations, then proceed; it has to be specific" (Policy-maker 22).
Governance values
•	 Enforcement of 
regulation
•	 Social 
participation
•	 Stewardship
•	 Transparency
To frame the problems as lack of stewardship, enforcement of regulation and corruption
•	 Several stakeholders pointed to the lack of conflict resolution mechanisms that could address the struggles in the health system by preventing the escalation of litigation and enforcing regulations designed to 
implement the legislation for the health system. 
To gain legitimacy in the policy-making process in the absence of meaningful citizen participation
•	 Stakeholders highlighted that the large number of guiding values  of the Colombian health system (currently 27) meant that decision-makers can easily define policies in relation to one or more of these goals 
thereby gaining legitimacy without meaningful engagement of citizens.
♦	 "You see that Chile has some very specific ones [values], very well defined, but in Colombia, you do not see that, you see the desire to include and include principles ... and that, at the moment of the truth, is 
not practical for Colombia. When you start looking, you can use anything, because the principle is there, whatever you want, you can do it because the principle is there, there are so many, that anything can 
be useful, whatever you want will serve anybody. I think it's the big mistake that Colombia has. It is easy, you first do and then look what value fits, it's the same when you set 80 goals, you can do anything 
that you want because it will point you to any goal. What you set can work accordingly for any goal" (Stakeholder 28).
Situational values
•	 Gradualism
•	 Human dignity
To shape policy development in a way that is aligned with the ideas of an influential interest group
•	 The Constitutional Court has given priority to the value of gradualism and human dignity. Gradualism has been defined as the progressiveness in the development and expansion of the protection of the right to 
health. Human dignity has been understood as the right to healthcare that allows an individual the physical and psychological integrity and empowerment. Those values have shaped health policy in a way that 
requires that it must always result in more services and technologies funded with public resources, and more people covered with those benefits. 
♦	 "It was reasonable that the benefits were full for those contributing for themselves and others, and that, after a time, when the sustainability of the system allowed, then, the benefits would be equal for all. 
That is reasonable, it is reasonable to restrict equality and equity for a time for reasons of sustainability, in order to reach equality, there is when this makes sense. Moreover, that is the way to harmonize 
them, but not as an irresponsible way of thinking that I can protect rights without any kind of economic reality and so on. Or the opposite, that it is an end in itself, and forgetting that this sustainability is 
being pursued to reach all people with equality and dignity" (Policy-maker 22).
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Values Identified Explanation of How the Values Were Used
Decision 2 - Mechanism of Exclusion of Technologies to be Funded With Public Resources
Goals-related 
values
•	 Equity
•	 Right to health
To frame the problem as a meaningful social concept for stakeholders and citizens
•	 Expensive technologies funded for low-prevalence diseases and only for citizens who can navigate in the judicial system (mainly middle and upper-middle classes) result in communicable and prevalent diseases 
in impoverished regions that are not supported by the system, which resulted in the recognition that the collective right to health was not ensured.
Technical values
•	 Cost-
containment
•	 Effectiveness
•	 Evidence-based
•	 Safety
•	 Sustainability
Influence the government agenda because the economic stability of the health system was at risk
•	 According to policy-makers, the Statutory Law practically ordered public funding for all technologies and services, risking the stability of the health system. This resulted in the need for a mechanism of exclusions 
in order to be able to also ensure the value of sustainability.
As pragmatic instruments to define the technologies and services covered
•	 A key example of how values were used as pragmatic instruments was in the discussion about the coverage of reconstructive surgery for women with breast cancer as the decision of the Court was that the 
nature of cosmetic or reconstructive surgery would be decided on scientific criteria and not supported by administrative or financial considerations of the insurance companies or the patient’s opinion. The court 
highlighted that cosmetic surgery is expressly excluded, while reconstructive or functional surgeries are understood to be included and under the responsibility of the insurance companies. 
Governance values
•	 Citizen 
engagement
•	 Social 
participation
•	 Transparency
To improve the acceptability of the policy
•	 The government considered successful national and international experiences with social participation and citizen engagement to improve the acceptability of the policy. However, patients’ organizations, health 
professionals, and social organizations fear that participating implies endorsement of policies with which they disagree.
Situational values
•	 Human dignity
To shape policy development in a way that is aligned with the ideas of an influential interest group
Patients, health professionals, and social organizations criticize the development of the mechanism of exclusions given they consider the value of human dignity was converted into rigid technical criteria. They 
advocate for the decisions to respect this value promoted by the court.
♦	 "How is this interpreted in reality? Everything cosmetic is excluded? the Court even puts a particular example, a child with prominent ears, because there was a tutela. The prominent ears do not cause any 
problem to the kid, the kid is healthy and can make a living, but is that other kids are bullying him, they are damaging their self-esteem, he will have emotional or psychological sequels. Is this case the same 
as the case of a lady who simply wants to have an augmentation mammoplasty to look better? Well, no. Those are 2 completely different cases" (Stakeholder 2).
Table 3. Continued
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putting in place real spaces for discussion and consideration 
of policies that solve health system problems. Since the 1990s, 
social participation has been encouraged, but the government 
has proposed mechanisms and moments of participation 
that are more about communicating the decisions than 
participating in their development. This phenomenon has 
led stakeholders (and some members of Congress) to reason 
that a request from the executive to participate or deliberate 
implies a request for them to legitimize or endorse a particular 
course of action, and that any contradictory position is not 
taken into account. In addition, stakeholders also highlighted 
that the large number of guiding values in the Colombian 
health system (currently 27) are being used as a shield against 
having to engage in meaningful democratic development of 
policies. As a result, decision-makers define any policy and 
subsequently link one or several of these guiding values 
to the policy in an attempt to legitimize the lack of social 
participation and citizen engagement.
Second Embedded Decision: Mechanism of Exclusion of 
Technologies
The Statutory Law mandated the executive to develop and 
implement a technical-scientific mechanism to define those 
services excluded from the core of the right to health, which 
would mean that patients were entitled to all technologies 
and services except those that are specifically excluded from 
the benefits plan.29 Feedback from the operation of current 
programs highlighted to the Court that previous definitions of 
benefits packages lacked transparency and the use of evidence-
based mechanisms for prioritizing what technologies should 
be publicly funded. To solve this problem, the Court asked for 
a public, collective, participatory, and transparent technical-
scientific procedure, which would consider 5 guiding 
principles for excluding technologies and procedures from 
public funding. These included: (1) procedures considered 
cosmetic, (2) procedures or technologies considered 
experimental, (3) technology without scientific evidence 
of effectiveness, (4) technology without approval of health 
authorities, and (5) procedures to be provided abroad when 
available in Colombia. 
The mechanism for exclusions was developed in 2017 
through Resolution 330 of the Ministry of Health.30 The 
Ministry led the process through which it promoted that 
stakeholders submit technologies that should be excluded, 
and engaged them in deliberative meetings to decide which 
technologies should be prioritized for exclusion from publicly 
funded benefits.
In this decision, policy-makers and stakeholders identified 
one similar value prioritized during the agenda-setting 
process and policy development (ie, financial sustainability), 
but they differed in the other prioritized values. For policy-
makers, the development of the mechanism for exclusions 
was informed by values such as effectiveness, financial 
feasibility, scientific evidence, universality, and values and 
preferences of citizens, while stakeholders prioritized cost 
containment and the profitability of different private actors 
as key values in the policy process. These discordant points of 
view about the values informing the policy process negatively 
affected the acceptance of the mechanism for exclusions by 
several stakeholders, who consider that it does not reflect the 
values promoted by the Constitutional Court (eg, gradualism 
and human dignity). These discordant points of view also 
led to the erosion of policy-makers’ confidence in social 
participation processes, and their view that citizens, patients, 
and doctors are not ready to be involved in the policy process, 
and that many Colombian citizens lack understanding of 
what a public good like healthcare means and therefore, they 
are not prone to protect the resources of the system.
For several stakeholders, the mechanism for exclusions 
proposed by the Ministry was inadequate. Specifically, 
interviewees argued that the Ministry converted the guiding 
principles ordered by the Court into rigid technical criteria, 
which they saw as being contrary to the spirit of the statutory 
law where each case should be defined according to the value 
of human dignity. In contrast, policy-makers viewed the issue 
in relation to the significant financial instability of the health 
system where virtually everything could be required to be 
publicly funded with resources from the health system.
Overall, this distrust in the process of policy development 
created a barrier to carrying out the orders of the Court. 
For example, stakeholders rejected many policies developed 
by the Ministry of Health because they perceived that 
international organizations (eg, WB, IMF, IDB) provided the 
‘recipe’ for health policies and that the Ministry of Health and 
other governmental institutions simply adapted the ‘recipe’ 
to the context. In addition, stakeholders opposed the policies 
developed by the Ministry as they viewed policy-makers as 
traditionally only having considered options that seek to 
reinforce the existing private health insurance model without 
considering whether those policy options can potentially 
solve the problems on the agenda. 
Discussion
The values more frequently and strongly explained by 
the interviewees in this study were individualism, free-
choice, and solidarity in Chile; human dignity, financial 
sustainability, and stewardship in Colombia; and effectiveness 
and social participation in both countries. We identified 
individualism in Chile as the only undeclared value (value not 
explicitly mentioned in policy documents or media), as well 
as undeclared interpretations of values explicitly named in 
policy documents (ie, the perception that social participation 
negatively affects the consideration of cost-effectiveness in 
decisions). 
In general, we identified 4 mechanisms for how values 
influence the decision-making, which include framing 
problems in meaningful ways, guiding the policy development 
process, using them as pragmatic instruments to make 
decisions, and using them to legitimize decisions. In Chile, 
we identified that values were also used as a way to ensure 
social mobility among citizens, and specifically to legitimize 
decisions that were meant to deflect attention from budget 
constraints (see Table 2). In Colombia, we identified that 
values were also used to gain legitimacy in the policy-making 
process in the absence of meaningful citizen participation, 
and to shape policies in a way that is aligned with the ideas of 
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an influential interest group (see Table 3). 
Comparing both countries and explaining why some values 
are incorporated in the policy-making process, we found that 
in the case of Chile, from policy-makers and stakeholders 
emerged that citizens are very attached to the values of free 
choice and individualism, which meant that they prioritized 
being able to join private plans. In contrast, while Colombia 
shares similar contextual and political characteristics 
with Chile, individualism was not mentioned in any of the 
interviews in Colombia. This difference may be explained 
by the influence of policy legacies, given that Chileans can 
voluntarily join the publicly financed or privately financed 
health system, while in Colombia affiliation with the publicly 
financed and privately managed health system is compulsory 
for all. While individualism appeared to play no role in the 2 
Colombian decisions studied, this value could still be relevant 
in Colombia if another topic (eg, prepaid medicine plans) 
were discussed, given that the people who commonly can 
afford these plans are recognized as belonging to the high-
income population. 
In the case of Colombia, the value of human dignity was 
incorporated in the policy decision-making process because 
of the judicial activism of the Constitutional Court. According 
to the interviewees, power in Colombia is concentrated in the 
executive branch of government (specifically, in the office of 
the president), which has prioritized financial sustainability 
over other values. The Court acted as a constitutional check 
on the decisions of the executive and legislative branches 
when it considered that the lack of the value of human dignity 
in the policy decision-making process was not living up to 
the branches’ constitutional requirements, and therefore 
must be included. This finding is similar to what Landau et 
al suggests as an explanation for the strong influence of the 
Constitutional Court in Colombia. According to Landau, the 
Court has responded to the instability of the political parties, 
poor social participation, and the weakness of the Congress 
in proposing policies and checking presidential power.31 
Moreover, it is said that the strong role of the judiciary branch 
is a signal of new or weak democracies, and in all cases, this 
kind of legislative substitution is inappropriate for the policy 
decision-making.31,32 
The smaller set of prioritized and often competing values 
identified in the 4 decisions, relates to how policy-makers and 
stakeholders consider them in decision-making and simplify 
the complex interplay influencing a particular decision to 
a few elements (values) that represent the extremes of the 
spectrum of points of views and policy alternatives to solve 
a problem; for example, the current law that organizes the 
health system of Colombia has 27 guiding values, which 
are impossible to address in each policy decision; however, 
dichotomizing values in tension facilitates stakeholders and 
policy-makers to identify and prioritize essential values in the 
policy process.
In a recent study about the values of public officials (not 
only in the health system), authors found that tensions 
between values and value trade‐offs are frequently founded in 
the public sector, principally when the decision-making imply 
allocation and redistribution of resources.33 In the analysis 
about the trade-off between efficiency and equity, authors 
suggest that public officials closer to the recipients of policies, 
are more pro-equity oriented, while public officials that have 
been exposed to private sector management, are more pro-
efficiency oriented.33 Our results are consistent with those 
of Fernández‐Gutiérrez and Van de Walle,33 but highlight a 
new actor as policy-maker, the judiciary sector. In our study, 
interviewees from the executive branch were more oriented 
to prioritize financial sustainability and efficiency, while 
interviewees from the judiciary branch were more oriented to 
human dignity and equity. 
Our study results should be interpreted carefully given 2 
important limitations. First, the number and composition 
of the sampling of participants in Colombia had twice the 
number of interviewers than in Chile, which was partially 
driven by us inviting more participants to engage a broader 
array of people with different ideological positions and 
professional backgrounds given the significant polarization 
of the perceptions about the health system in Colombia, 
and the role of the Judiciary branch. In Chile, the agreement 
between different views of the health system and the values 
that inform the decisions were greater and, as a result, we 
reached saturation with fewer participants. Second, the 
imbalance in participants from each country, given that in 
Colombia we interviewed policy-makers belonging to the 
judiciary, legislative, and executive branches, while in Chile 
we only interviewed policy-makers from the executive. 
The principal reason for this is that the judiciary branch is 
not involved in the health policy decision-making in Chile 
and that during the fieldwork for this study Chile was in an 
electoral period and, as a result, it was not possible to conduct 
an interview with a member of congress during that period of 
time. This limitation was minimized given that we reviewed 
the transcriptions of public debates about AUGE/GES plan in 
the Chilean Congress, and we did not identify a divergence 
between the statements of members of Congress in those 
hearings and the insights of policy-makers participating in 
this case study.
Conclusion
The study of values in the policy decision-making process 
in Latin America is an emerging field. Our effort to analyze 
health-system financing policies in Chile and Colombia using 
analytical frameworks related to government agenda setting, 
policy development and implementation and by considering 
the influence of societal values is a unique contribution to the 
body of knowledge in this field. As such, it is an opportunity 
to open further exploration of the role of values in different 
health decisions, political sectors besides health, and even 
other jurisdictions.
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